Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Last update: Oct 29, 2026

Details

Location: EU 27
Contracting Authority: Horizon Europe (2021 - 2027)
Contracting Authority Type: Development Institution
Status: Open
Budget: EUR 38,000,000
Award ceiling: 10,000,000
Award floor: 8,000,000
Sector: Health
Eligible applicants: Unrestricted / Unspecified
Eligible nationalities: Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Aruba, Austria, Azerbaijan, Bangladesh, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Curaçao, Cyprus, Czech Republic, Dem. Rep. Congo, Denmark, Djibouti, Dominica, Commonwealth of, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini (Swaziland), Ethiopia, Faroe Islands, Fiji, Finland, France, French Polynesia, French Southern Territory, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Micronesia, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, North Macedonia, Norway, Pakistan, Palau, Palestine / West Bank & Gaza, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Rwanda, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Senegal, Serbia, Sierra Leone, Sint Maarten, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Korea, South Sudan, Spain, Sri Lanka, St. Pierre and Miquelon, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Türkiye, Turkmenistan, Tuvalu, Uganda, UK, Ukraine, Uzbekistan, Vanuatu, Venezuela, Vietnam, Wallis and Futuna, Yemen, Zambia, Zimbabwe
Date posted: Dec 12, 2025

Quick Summary

Objectives: 

Objectives

  • Purpose: Support research that reduces adverse drug reactions linked to the use of three or more medicines, with a focus on safer and more effect...
Eligibility criteria: 
  • Eligible applicants: Any legal entity may participate, including beneficiaries, affiliated entities and associated partners. Start-ups, micro, small and medium-sized enterprises are encouraged to participate. The action is a Horizon Europe Research and Innovation Action.
  • Geographic and legal eligibility: Eligible countries follow the Horizon Europe rules. Any legal entity establi...
Share

Similar grants

By Locations
Funding Agency: NGO
Status: open
Location: Ireland, UK
Funding Agency: EC
Status: open
Location: Cyprus
By Sectors
Funding Agency: US CDC
Status: open
Location: USA
Funding Agency: Government
Status: open
Location: Norway